Company intelligence / Profile preview

Mol3D Research

Oxford, Oxfordshire, United Kingdom

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Mol3D is an AI-driven biotechnology company specializing in the generative design of 3D molecular structures for drug discovery. The company leverages advanced machine learning and physics-based simulations to accelerate the identification of high-affinity small molecule leads. By focusing on the spatial orientation and 3D interactions of molecules, Mol3D aims to overcome the limitations of traditional 2D-based screening methods. Their platform is designed to optimize drug-like properties and binding efficiency early in the development process.

Modalities: Small molecule
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Mol3D Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mol3D Research.

Explore the full profile